Q-Line Biotech Limited

Following are the details as per the restated financial statements for the financial years ended on March 31, 2025, March 31, 2024 and March 31, 2023:

(₹ in Lakhs)

<table><thead><tr><th rowspan="3">Sr. No</th><th rowspan="3">Particulars</th><th colspan="3">For the period/ year ended</th></tr><tr><th>March 31, 2025</th><th>March 31, 2024</th><th>March 31, 2023</th></tr><tr><th colspan="3">Consolidated</th></tr></thead><tbody><tr><td>1.</td><td>Equity Share Capital</td><td>157.50</td><td>157.50</td><td>157.50</td></tr><tr><td>2.</td><td>Net Worth</td><td>18,994.53</td><td>16,181.44</td><td>12,736.52</td></tr><tr><td>3.</td><td>Total Income</td><td>32,258.42</td><td>20,644.81</td><td>18,481.15</td></tr><tr><td>4.</td><td>Profit/(loss) after tax</td><td>2,813.09</td><td>3,444.47</td><td>3,209.71</td></tr><tr><td>5.</td><td>Earnings per Share (based on weighted average number of shares)</td><td>28.63</td><td>21.87</td><td>20.38</td></tr><tr><td>6.</td><td>Net Asset Value per Share (based on actual number of shares)</td><td>1,206.00</td><td>1,027.39</td><td>808.67</td></tr><tr><td>7.</td><td>Net Asset Value per Share (based on Weighted Average Number of Shares)</td><td>120.60</td><td>102.74</td><td>80.87</td></tr><tr><td>8.</td><td>Total Borrowings (including current maturities of long-term borrowings)</td><td>16,494.98</td><td>9,691.00</td><td>7,364.84</td></tr></tbody></table>

## G. AUDITOR QUALIFICATIONS

There are no audit qualifications which have not been given effect in the Restated Financial Statements.

## H. SUMMARY OF OUTSTANDING LITIGATIONS

A summary of outstanding litigations proceedings involving our Company, Promoters, Directors, KMPs, Group Company and Subsidiary Company as on the date of this Draft Red Herring Prospectus are as below:

<table><thead><tr><th>S. No.</th><th>Name of Entity</th><th>Criminal Proceedings</th><th>Tax Proceedings</th><th>Material Civil Litigations</th><th>Aggregate amount involved (₹ in lakhs)</th></tr></thead><tbody><tr><td rowspan="2">1.</td><td><strong>Company</strong></td><td></td><td></td><td></td><td></td></tr><tr><td>By the Company</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td></td><td>Against the Company</td><td>-</td><td>5</td><td>-</td><td>154.75</td></tr><tr><td rowspan="2">2.</td><td><strong>Subsidiary</strong></td><td></td><td></td><td></td><td></td></tr><tr><td>By the Subsidiary</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td></td><td>Against the Subsidiary</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td rowspan="2">3.</td><td><strong>Promoters*</strong></td><td></td><td></td><td></td><td></td></tr><tr><td>By the Promoters</td><td>1</td><td>1</td><td>1</td><td>44.63</td></tr><tr><td></td><td>Against the Promoters</td><td>-</td><td>8</td><td>4</td><td>164.56</td></tr><tr><td rowspan="2">4.</td><td><strong>Directors (other than Promoters)</strong></td><td></td><td></td><td></td><td></td></tr><tr><td>By the Directors</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td></td><td>Against the Directors</td><td>-</td><td>-</td><td>2</td><td>Unascertainable</td></tr><tr><td rowspan="2">5.</td><td><strong>Key Managerial Personal & Senior Management</strong></td><td></td><td></td><td></td><td></td></tr><tr><td>By the Company</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td></td><td>Against the Company</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td rowspan="2">6.</td><td><strong>Group Companies (Material to our Company)</strong></td><td></td><td></td><td></td><td></td></tr><tr><td>By the Group Companies</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td></td><td>Against the Group Companies</td><td>-</td><td>6</td><td>-</td><td>360.10</td></tr></tbody></table>

*Includes the litigation proceedings pertain to POCT Services, a partnership firm in which our Promoters, Saurabh Garg and Amita Garg, are partners.

For further details, please refer to the chapter titled "Outstanding Litigations and Material Developments" on page 257 of this Draft Red Herring Prospectus.

## I. RISK FACTORS

For details on the risks involved in our business, please see the Chapter titled "Risk Factors" beginning on page 29 of this Draft Red Herring Prospectus.

## J. SUMMARY OF CONTINGENT LIABILITIES

(₹ in lakhs)

<table><thead><tr><th>Particulars</th><th>As at</th></tr></thead></table>

22